Actemra Heart Failure & Pancreatitis Lawyers in New York

Personal Injury Lawyers in New York City, Serving Clients Nationally

Actemra (tocilimuzab) is a rheumatoid arthritis drug in the IL-6 family
that is manufactured, distributed, and sold by Roche. STAT, an independent
medical news organization, has recently studied reports of adverse health
effects suffered by people using Actemra and other similar rheumatoid
arthritis drugs. STAT found in some instances the side effects were higher
in Actemra patients, but unlike other rheumatoid arthritis drugs,
Actemra does not have warnings for these side effects.

Side effects that have been linked to Actemra use include:

Pancreatitis

Heart failure

Heart attack

Stroke

Interstitial lung disease

Death

Actemra is a biologic, which works by inhibiting the chemical signal interleukin-6
(IL-6), a chemical signal that causes inflammation. The Food and Drug
Administration (FDA) is now being asked to reevaluate the causality and
frequency of these side effects, which had already been investigated several
times by the administration for other similar drugs. Concern has spiked
recently after Acterma became the first drug approved to treat giant cell
arteritis, and increased usage of the drug is expected.

Were you or a loved one diagnosed with a serious health condition after
taking Actemra? Our New York Acterma lawsuit attorneys would like to hear
your claims. Call (888) 260-0473 to speak to us today.

NYC Dangerous Drug Attorneys On Your Side

At Rheingold Giuffra Ruffo & Plotkin LLP, our New York product liability
attorneys have extensive experience handling cases involving
dangerous drugs,
personal injury claims, and
wrongful death, including drug-induced pancreatitis from diabetes medications. We are
dedicated to helping individuals achieve financial and emotional relief
from the undue physical hardships and overwhelming medical costs they
have endured due to a defective drug or prescription medicine. To gain
a strategic advantage for our clients, we file all suits, negotiate settlements,
and litigate cases individually. We make a point to get to know our clients
personally, as well as handle claims ourselves without involving other
firms, which often complicates a process and damages a claim’s validity.

People choose to work with our New York dangerous drug lawyers due to our
accolades and accomplishments, including:

The sooner you start your case, the stronger it will be. Contact usat your first opportunity.

Constructing a Strong Plaintiff Case for You

Plaintiffs in Actemra accuse the manufacturers of designing defective drugs,
failing to warn consumers and medical professionals, breach of warranty,
negligent misrepresentation, and fraudulent concealment. Lawsuits for
defective drug injuries can be incredibly complex and revolve around life-changing
or fatal conditions, such as a cancer developed by rheumatoid arthritis
medication. If you or someone you love has suffered due to the negligence
of a drug manufacturer, it is important to speak to an experienced lawyer
who can understand all aspects of your case and manage it confidently
on your behalf.

Our New York Actemra lawsuit attorneys can:

Study and compile all relevant evidence to your case.

Prepare an argument for negotiations or litigation.

Seek compensation for injuries, medical expenses, pain and suffering, and
other economic damages, as well as punitive damages you need to make it
through this difficult time.

Make sure others are protected from these destructive practices by holding
big pharmaceutical companies accountable for their negligence.

If you or a loved one developed pancreatitis or another health condition
after taking Actemra, please contact ustoday, either using an online evaluation form or by calling (888) 260-0473
to speak with an experienced New York drug product liability law firm.
Free consultations are available.

The information on this website is for general information purposes only.
Nothing on this site should be taken as legal advice for any individual
case or situation. This information is not intended to create, and receipt
or viewing does not constitute, an attorney-client relationship.

x

⚠

Your browser is out of date. To get the full experience of this website,
please update to most recent version.